Time Medical International Ventures (India) has become the first Magnetic Resonance Imaging (MRI) manufacturer in India to receive the official license to manufacture for sale or distribution of Magnetic Resonance Diagnostic Devices (MRDD) from the CDSCO. With this new license, Time Medical will manufacture and distribute the following MRI systems, some of which are FDA and CE approved as well, ensuring compliance with global safety, quality, and regulatory standards: EMMA - 1.5T MRI Scanner, PICA - 0.35T MRI Scanner, MICA - 1.5T MRI Scanner and QUIN - 1.5T MRI Scanner. The EMMA, MICA, and QUIN MRI systems are 1.5T MRI scanners, offering exceptional imaging resolution and precision for a wide range of clinical applications, while the PICA model is a 0.35T MRI scanner, tailored for specific diagnostic needs. These models are available for distribution across India, helping to address the growing demand for reliable and advanced medical imaging solutions. We are thrilled to be the first Make in India company to receive the CDSCO license for the manufacturing and distribution of MRI systems. This achievement demonstrates the strength and potential of India's medical device manufacturing sector. With our EMMA, PICA, MICA, and QUIN MRI systems, we are committed to providing hospitals and diagnostic centers with cutting-edge, affordable diagnostic imaging solutions,' said the Management Team of Fischer Medical Ventures. Fischer Medical Ventures has changed the nature of Business from Manufacturing of Chemicals to Trading and Manufacturing of Medical equipment including MRI machines consequent to share subscription agreement. The company reported consolidated net profit of Rs 0.29 crore in Q2 FY25 as against net loss of Rs 0.12 crore in Q1 FY25. Net sales surged 291.9% YoY to Rs 39.66 crore in the September 2024 quarter. Powered by Capital Market - Live

Fischer Medical Ventures announced that its wholly owned subsidiary, Time Medical International Ventures (India) has become the first indigenous MRI manufacturer in India to receive the official License to Manufacture for Sale or Distribution of Magnetic Resonance Diagnostic Devices (MRDD) from the Central Drugs Standard Control Organization (CDSCO). This achievement marks a significant milestone in the Make in India initiative, reinforcing the company''s commitment to developing high-quality, locally manufactured medical devices that meet international standards. With this new license, Time Medical will manufacture and distribute the following MRI systems, some of which are FDA and CE approved as well, ensuring compliance with global safety, quality, and regulatory standards: 'h EMMA - 1.5T MRI Scanner 'h PICA - 0.35T MRI Scanner 'h MICA - 1.5T MRI Scanner 'h QUIN - 1.5T MRI ScannerPowered by Capital Market - Live

Fischer Medical Ventures announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 31 January 2025.Powered by Capital Market - Live

Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 3 January 2025.Powered by Capital Market - Live

The Board of Fischer Medical Ventures will meet on 03 January 2025 to consider and approved: 1. The withdrawal of the proposed preferential issue which was announced by the Company on 14 August 2024; 2. The proposal for fund raising by way of preferential issue / private placement of securities for cash / other than cash, including determination of Issue Price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the Company.Powered by Capital Market - Live

Net profit of Fischer Medical Ventures rose 264.29% to Rs 0.51 crore in the quarter ended September 2024 as against Rs 0.14 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 as against Rs 0.19 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales00.19 -100 OPM %073.68 - PBDT0.460.15 207 PBT0.460.15 207 NP0.510.14 264 Powered by Capital Market - Live

The Board of Fischer Medical Ventures at its meeting held on 13 November 2024 has approved the appointment of Vivek Balasubramanian as the Chief Financial Officer of the Company with effect from 13 November 2024. The Board accepted the resignation of Dilip Suryakant Jha who resigned as Chief Financial Officer of the Company with effect from 12 November 2024. Powered by Capital Market - Live

Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live

Fischer Medical Ventures announced that the 31th Annual General Meeting (AGM) of the company will be held on 17 September 2024.Powered by Capital Market - Live

Net profit of Fischer Medical Ventures reported to Rs 0.84 crore in the quarter ended June 2024 as against net loss of Rs 0.22 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live